No Prescription |
 |
 | ||
|
Vicrom 5 Tilade |
|
| ||
No Prescription » Prescription Drugs 17 » Vicrom 5 Tilade Nedocromil sodium is a type of anti-inflammatory medicine that is not a corticosteroid. It prevents tissues becoming inflamed when an allergic reaction occurs. It is not fully understood how nedocromil prevents inflammation but it is thought to work by preventing the release of inflammatory chemicals from cells called mast cells. Mast cells are cells in the immune system that become sensitised in response to foreign particles or allergens. When this happens they release chemicals including histamine that go on to cause inflammation as part of the bodyÆs allergic response. Allergic inflammation in the lungs is one of the causes of asthma. It causes mucus production and narrows the airways making it difficult to breathe. As nedocromil reduces the inflammation in the lungs it makes it easier to breathe and helps prevent asthma attacks. It should be used regularly even when you have no asthmatic symptoms to reduce the inflammation in the lungs.Nedocromil can also be useful for preventing shortness of breath caused by exercise. You should check with your doctor before using it for this purpose though as if exercise brings on wheezing or shortness of breath it may mean that your asthma is getting worse or is not very well controlled. If so your doctor may need to prescribe you another medicine.Tilade CFC-free inhaler is a device that is used to inhale the nedocromil. Inhaling the medicine allows it to act directly in the lungs where it is needed most. It also reduces the potential for side effects occurring in other parts of the body as the amount absorbed into the blood through the lungs is lower than if it is taken by mouth.Used for Asthma Buy Vicrom 5 Tilade and other Prescription Drugs 17 products online at Medstore. 146
About Vicrom 5 Tilade: Product Type: Prescription Drugs 17 Vicrom 5 ( Tilade Generic Nedocromil ) Vicrom 5 (Tilade Generic Nedocromil) Tilade Generic Nedocromil 5mg/dose 112 dose Tilade Generic Nedocromil Vicrom 5
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
